Publication:
Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy followed by concurrent chemoradiotherapy with cisplatin in locally advanced stage III and IV nasopharyngeal cancer.

Simple item page
dc.contributor.authorsDane, Faysal; Atasoy, Beste Melek; Akgun, Zuleyha; Yumuk, Fulden; Cabuk, Devrim; Teomete, Mehmet; Basaran, Gul; Turhal, Serdar; Abacioglu, Ufuk
dc.date.accessioned2022-03-12T16:13:55Z
dc.date.accessioned2026-01-11T10:49:55Z
dc.date.available2022-03-12T16:13:55Z
dc.date.issued2012
dc.identifier.doidoiWOS:000318009800270
dc.identifier.eissn1527-7755
dc.identifier.issn0732-183X
dc.identifier.urihttps://hdl.handle.net/11424/225152
dc.identifier.wosWOS:000318009800270
dc.language.isoeng
dc.publisherAMER SOC CLINICAL ONCOLOGY
dc.relation.ispartofJOURNAL OF CLINICAL ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleDocetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy followed by concurrent chemoradiotherapy with cisplatin in locally advanced stage III and IV nasopharyngeal cancer.
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.issue15
oaire.citation.titleJOURNAL OF CLINICAL ONCOLOGY
oaire.citation.volume30

Files

Collections

Araştırma Çıktıları